help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nicholson, G. C.
Right arrow Articles by Martin, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nicholson, G. C.
Right arrow Articles by Martin, T. J.

Endocrinology, Vol 120, 1902-1908, Copyright © 1987 by Endocrine Society


ARTICLES

Control of cyclic adenosine 3',5'-monophosphate production in osteoclasts: calcitonin-induced persistent activation and homologous desensitization of adenylate cyclase

GC Nicholson, JM Moseley, AJ Yates and TJ Martin

Hormonal control of cAMP production in the osteoclast has not been investigated in detail because this bone-resorbing cell has been difficult to isolate. We have used osteoclasts freshly isolated by disaggregation from neonatal rat long bones and settled onto coverslips (100-150 cells per coverslip) to examine the effects of calcitonin and prostaglandin E2 on osteoclast cAMP levels and cytoplasmic spreading. Salmon, eel, and human calcitonin (CT), and various analogs, stimulated cAMP production in a dose-dependent manner with relative potencies as seen in other response systems. Forskolin (10(-7) M) increased the sensitivity and amplitude of the response. Pretreatment with pertussis toxin (200 ng/ml for 3 h) had no effect suggesting that CT does not act through Ni, the inhibitory guanine nucleotide regulatory unit of adenylate cyclase. CT treatment was associated with rapid and dose- dependent induction of a persistent activated state of adenylate cyclase and homologous desensitization, the former being a particular feature of CT action previously observed in nonosteoclastic cells. Quantitative histomorphometry demonstrated a sensitive, dose dependent, and prolonged (greater than 2 h) reduction in osteoclast plan area after exposure to salmon CT. Although prostaglandin E2 also stimulated cAMP production and resulted in cell contraction in osteoclasts this was not associated with persistent activation of adenylate cyclase nor with prolonged contraction. Persistent activation of adenylate cyclase may be an important mechanism in CT inhibition of osteoclast function.


This article has been cited by other articles:


Home page
J EndocrinolHome page
S. Paul, D. Mukherjee, K. Pramanick, S. Kundu, S P Bhattacharyya, P. De, and D. Mukherjee
Stimulation of salmon calcitonin on secretion of 17{beta}-estradiol by the ovarian follicles of common carp, Cyprinus carpio
J. Endocrinol., February 1, 2008; 196(2): 413 - 424.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
D. R. Poyner, P. M. Sexton, I. Marshall, D. M. Smith, R. Quirion, W. Born, R. Muff, J. A. Fischer, and S. M. Foord
International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors
Pharmacol. Rev., June 1, 2002; 54(2): 233 - 246.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Wada, S. Yasuda, T. Nagai, T. Maeda, S. Kitahama, S. Suda, D. M. Findlay, M. Iitaka, and S. Katayama
Regulation of Calcitonin Receptor by Glucocorticoid in Human Osteoclast-Like Cells Prepared in Vitro Using Receptor Activator of Nuclear Factor-{{kappa}}B Ligand and Macrophage Colony-Stimulating Factor
Endocrinology, April 1, 2001; 142(4): 1471 - 1478.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
A. Samura, S. Wada, S. Suda, M. Iitaka, and S. Katayama
Calcitonin Receptor Regulation and Responsiveness to Calcitonin in Human Osteoclast-Like Cells Prepared in Vitro using Receptor Activator of Nuclear Factor-{kappa}B Ligand and Macrophage Colony-Stimulating Factor
Endocrinology, October 1, 2000; 141(10): 3774 - 3782.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S.-C. Tsai, C.-C. Lu, J.-J. Chen, Y.-C. Chiao, S.-W. Wang, J.-J. Hwang, and P. S. Wang
Inhibition of salmon calcitonin on secretion of progesterone and GnRH-stimulated pituitary luteinizing hormone
Am J Physiol Endocrinol Metab, July 1, 1999; 277(1): E49 - E55.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Inoue, C. Shih, D. L. Galson, S. R. Goldring, W. C. Horne, and R. Baron
Calcitonin-Dependent Down-Regulation of the Mouse C1a Calcitonin Receptor in Cells of the Osteoclast Lineage Involves a Transcriptional Mechanism
Endocrinology, March 1, 1999; 140(3): 1060 - 1068.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
D Zhang, N Udagawa, I Nakamura, H Murakami, S Saito, K Yamasaki, Y Shibasaki, N Morii, S Narumiya, N Takahashi, et al.
The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts
J. Cell Sci., January 6, 1995; 108(6): 2285 - 2292.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1987 by The Endocrine Society